Abstract
To meet increasing demand for animal protein, swine have been raised in large Chinese farms widely, using antibiotics as growth promoter. However, improper use of antibiotics has caused serious environmental and health risks, in particular Antimicrobial resistance (AMR). This paper reviews the consumption of antibiotics in swine production as well as AMR and the development of novel antibiotics or alternatives in China. The estimated application of antibiotics in animal production in China accounted for about 84240 tons in 2013. Overuse and abuse of antibiotics pose a great health risk to people through food-borne antibiotic residues and selection for antibiotic resistance. China unveiled a national plan to tackle antibiotic resistance in August 2016, but more support is needed for the development of new antibiotics or alternatives like plant extracts. Antibiotic resistance has been a major global challenge, so international collaboration between China and Europe is needed.
Introduction
Over the last decades, China's economy has grown very quickly. The gross domestic product (GDP) increased from 1.21 trillion US$ in 2000 to 10.35 trillion US$ in 2014 (Figure 1, World Bank, 2016). During the same period, Chinese production of meat, eggs, and milk has rapidly increased, and this will continue—especially for pork (–). Pork is one of the most important sources of animal protein in the country, and its production has jumped from around 40 million tons in 2000 to approximately 56 million tons in 2014 (Figure 1, USDA, 2016). The effects of the global financial crisis in 2007 and swine flu in 2011 caused an AMRupt production decline in these 2 years. However, production of swine quickly rebounded in the subsequent years. Concurrently, China's pork consumption increased from 2000 to 2014, with some drops in 2007 and 2011. Since 2012, pork consumption has been slightly higher than production, indicating that the pork demand of Chinese consumers has exceeded the domestic production.
Figure 1
Along with a rapid increase in pork production, both the number and the size of intensive swine farms have grown. The number of big farms with thousands of swine has increased markedly. The percentage of big swine farms, with herd sizes of more than 3,000, increased from 5% in 2003 to 14% in 2010. In the same period, the proportion of small farms, with herd sizes of less than 50, nearly halved, from 71% to 36% (China Animal Industry Yearbook 2004–2011).
Several recent studies detail antibiotic use in animal production (–) and the risk this poses in the form of antibiotic resistance (–). The current study focuses on the important emerging public health challenges as a result of overuse or abuse of antibiotics in swine production in China. It also outlines the future challenges for the new antibiotics and alternatives.
Antibiotic Usage in Swine Production in China
With the shift from small to large swine feeding operations and the increase in overall pork production, there is growing concern about the adverse consequences such as swine health and welfare, disease spreading of large-scale animal production (). Because the high density of animals in big swine farms exacerbates the risk of quick spread of infectious diseases, farmers in China have responded by using higher amounts of antibiotics. This, in turn, has led to growing concerns regarding overuse and abuse of antibiotics for intensive swine production, especially the health risks (, , ).
Penicillin was discovered in the 1940s. Since then, antibiotics have changed the treatment of bacterial infections for both humans and animals. Antibiotics were first added to feed for broiler poultry to prevent microbial diseases in the 1940s (). They were then rapidly used for the same purpose in feed for other food animals, first in the USA and later in other developed countries and developing countries such as China (). Antibiotics can aid in different ways. When antibiotics are used at low (sub-therapeutic) levels in feed, they can improve growth rate by reducing mortality and disease. Thus, conversion of feed to weight gain becomes more efficient. Antibiotics can further prevent disease at intermediate levels, whereas high (therapeutic) levels of antibiotics are used to treat diseases (–). Antibiotics are widely used in animal husbandry as low-cost growth promoters in more than half of the world's countries ().
As the world's largest pork producer and consumer, China uses a massive amount of antibiotics to support its production (). Some studies have been conducted to identify the antibiotics used in China's pig farms (–). These studies report the extensive use of the major antibiotic classes of sulphonamides, tetracyclines, fluoroquinolones, macrolides, and β-lactams.
Antibiotics have been widely adopted for use in food animals, but reliable data about the quantity and patterns of use (e.g., dose and frequency) for food animals alone are not easily available in China or other developing countries. It is very challenging to make an accurate calculation of antibiotic use in food animals. Studies have adopted different classifications for therapeutic use, nontherapeutic use, or a combination of the two. Most available data lack clear definition of therapeutic vs. nontherapeutic uses, and this ambiguity clearly erodes reliability (). Based on models developed from American data (), Krishnasamy et al. () estimated that 38.5 million kg of antimicrobials were consumed in China's pork and poultry production in 2012. Among all antibiotics, tetracyclines are the most widely consumed in swine production. Zhang et al. () performed a market survey on the usage of the 36 main antibiotics in China including sulfonamides, tetracyclines, fluoroquinolones, macrolides, β-lactams (penicillins and cephalosporins), chloramphenicols, lincomycin, and others. They found that the total amount of antibiotics used for China's swine farming was 48.4 million kg in 2013, which is higher than the result of Krishnasamy et al. (). Of all antibiotics consumed in China's swine farming, fluoroquinolones and β-lactams contributed more than half.
Moreover, there is a clear geographic heterogeneity for antibiotic consumption in China. Antibiotic consumption hotspots appear in Southwest China (Sichuan), Central China (Hunan), North China (Henan and Hebei) and the southeast coast (Fujian, Guangdong and Guangxi) in China. In particular, Sichuan province has the highest swine density and therefore carries the most serious risks to environment and health (). Other areas have also seen significant developments in recent years. For example, Xinjiang Uyghur Autonomous Region, the provincial level region with the largest area in Northwest China, is located in the center of the Eurasian continent. It is in the core area of “The Silk Road Economic Belt” and plays an important role in this program. Pork production in Xinjiang increased from 0.025 million tons in 1978 to 0.231 million tons in 2010 (Statistical Yearbook of Xinjiang in 2011). Despite a lack of data on antibiotic consumption in swine farms in Xinjiang, the concentration and detection rate of antibiotic residue in swine manure samples were higher than those of chicken manure and cow dung. The concentration of tetracycline in swine manure was highest, followed by sulfonamides and quinolones (, ). Additionally, international trade with Central Asian and European countries is increasing along the Silk Road, which may worsen the spread of antibiotics. In Lake Aibi, 12 species of 14 kinds of antibiotics were detected and detection rates of four kinds of antibiotics were 100% in water samples, with highest average concentration of 54.37 ng L−1 (, ).
China is tackling the overuse of antibiotics and the AMR problem using different approaches, including educating farmers about AMR caused by excessive use of antibiotics in animal farming, swiftly banning the use of colistin as a feed additive in animal production (), reducing the list of approved antibiotics for animal application, promoting the use of alternative feed additives such as organic acids (e.g., Selko®-pH, http://selko.com), improving the management of animal husbandry and animal welfare, and law enforcement accompanied by an effective surveillance system [(), http://www.moa.gov.cn/].
Antibiotic Resistance and the Risk to Human Health
The overuse and abuse of antibiotics cause environmental pollution, for example the contamination of manure, soil and water (, ). Worse, improper use of antibiotics brings risk to human health through food-borne antibiotic residues and selection for AMR, and a greater ability of certain bacteria to resist the effect of antibiotic treatments (). The causes of AMR are complex, but there is growing scientific evidence suggesting that low-dose, prolonged courses of antibiotic use for animal husbandry accelerated the emergence and spread of resistant bacteria (–). In food animal husbandry, AMR can spread not only by direct contact, but also indirectly (Figure 2). Direct effects are those that can be causally linked to contact with antibiotic-resistant bacteria from swine. Indirect effects are those that result from contact with resistant organisms that have been spread through food, water, and animal waste application to soil ().
Figure 2
Many antibiotic classes are used in both swine husbandry and human health care. Therefore, the emergence and spread of resistance to these antibiotics will likely limit the therapeutic options for human diseases. Even worse, this kind of AMR can prolong illness and cause serious disability and ultimately death (, ).
In the last decades, AMR has become a global challenge for human health and welfare. In particular, it is a serious problem in China where antibiotics have been overused or misused in livestock husbandry and human health care (–). For example, the OqxAB efflux pump, encoded by the genes oqxA and oqxB, has been found to be one of the mechanisms of plasmid-mediated quinolone resistance (PMQR) (–). Zhao et al. () investigated the prevalence and dissemination of oqxAB in Escherichia coli (E. coli) isolates from swine, their environment and farmworkers in China. The oqxA gene was present in around 39.0% of E. coli isolates. About 46.3% of E. coli isolates from swine farms were positive for oqxA. Approximately 43.9% of E. coli isolates from the swine farm environment were also positive. In addition to animal E. coli isolates, oqxAB was found in 30.3% of human commensal E. coli isolates. Because these farmworkers were without previous antimicrobial treatment or hospital admission, this indicated the transmission of oqxAB to humans. Compared with results from Sweden (1.8%) and South Korea (0.4%) (, ), the prevalence of oqxAB in E. coli isolates was much higher (39.0%) in China ().
A further example has been reported by Zhang et al. (), who researched the occurrence of the aac (3)-IV gene, which confers resistance to apramycin, an antibiotic used in agriculture but not for humans, in Northeast China. Unfortunately, they found workers who carried apramycin resistance genes in all swine farms where apramycin was used as an antibiotic growth promoter. The same was present in swine isolates. Similarly, Ho et al. () investigated gentamicin resistance in Hong Kong. They found that 84.1% of human samples and 71.4% of swine samples contained the aaaC2 gene for gentamicin resistance. Polymyxin resistance was identified as being due to the plasmid-mediated mcr-1 gene (). Liu et al. () investigated the mcr-1 gene in swine, pork and inpatients in five provinces in China during the period 2011–2014. They found mcr-1 in E. coli isolates collected from 17.7% of pork samples, 20.23% of swine samples, and 1.40% of inpatient samples with infection. Similar studies have also been conducted in Xinjiang. For example, Xia et al. () collected 543 fecal samples from a large-scale swine farm and isolated 454 E. coli isolates. They found that 64.5% of the E. coli isolates showed resistance to 3–9 antimicrobials, especially to ampicillin and amoxicillin.
The Development of New Antibiotics
Concern about antibiotic resistance has escalated in the last years. In 1986, Sweden became the first country in the world to ban the use of some antibiotics in animal feeds (). In 2006, European Union (EU) member nations started to ban all antibiotic growth promoters according to EC Regulation No. 1831/2003 (). As the largest developing country with a growing demand for meat protein, China has not yet completely prohibited the use of antibiotics as growth promoters. Considering the big risk for antibiotic pollution in the environment (soil and water) and potential resistance, more research is urgently needed for the development of new antibiotics or, ideally, alternatives.
New Antibiotics
During the past two decades, efforts to develop new antibiotics have met with some success (). However, due to their much higher costs compared to the older antibiotics, many have been gradually pulled from the market. Therefore, new antibiotics are still needed to tackle the worsening risk of antibiotic resistance.
Several approaches have been applied to identify new antibiotics or augment currently licensed antibiotics: (1) natural or synthetic compounds as inhibitors of multidrug efflux pumps, (2) small-molecule inhibitors of bacterial transcription factors, and 3) antisense inhibition of multidrug transporter genes using licensed drugs (–59). As alternatives to antibiotics, use of bacteriophage and plant extracts has also been investigated, which will be discussed in the next section.
By deleting or inactivating specific genes, researchers found some putative new targets, for example reducing the virulence of pathogens (60, 61). Quorum sensing (QS) or other bacterial signaling systems have also been identified as new targets for antibiotic molecules (62, 63). In-silico and in vitro high-throughput screening of small-molecule and compound libraries have also been increasingly used. Some agents have been in Phase 1 of clinical trials (64). In 2015, Ling et al. (65) discovered a “resistance-free” teixobactin in a screen of uncultured soil bacteria sample. Experiments confirmed no mutants of Staphylococcus aureus or Mycobacterium tuberculosis resistant to this teixobactin. Hopefully, this study will start an innovative approach to expanding the pool of natural antibiotics (66). Recently, a new class of antibiotics—arylomycins—was reported (67). The arylomycin G0775 showed activity against multi-drug resistant Gram-negative clinical bacterial pathogens by inhibiting the essential bacterial type I signal peptidase (which is a novel antibiotic target) through an unknown mechanism as described by Smith et al. (67). Further investigation will hopefully reveal the molecular mechanism underlying this novel class of antibiotics originating from natural products. Efforts will be made to identify and characterize more novel natural products to tackle AMR and problems caused by over-application of antibiotics in swine production.
Plant Extracts—a Promising Alternative
In addition to searching for new antibiotics, alternatives/replacements have received growing attention in the last decades (, 68). Researchers have explored various kinds of alternatives to animal antibiotics: feeding enzymes, immunity modulating agents, bacteriophages and their lysines, antimicrobial peptides, probiotics, prebiotics, synbiotics, inhibitors targeting pathogenicity, plant extracts and others (, 69–75). In China, herbs and their extracts have been widely used in traditional medicine for centuries before the introduction of western medicine. Youyou Tu, from the China Academy of Traditional Chinese Medicine in Beijing, was awarded the 2015 Nobel Prize in Physiology or Medicine for her discovery of artemisinin (qinghaosu) extracted from Artemisia annua L. (76). Her work was inspired by the Chinese traditional medical book Prescriptions for Emergencies by Ge Hong (284–346 CE) (77). Compared to other antibiotic alternatives, therefore, plant extracts have received more attention and support in China.
Natural plant products and their derivatives have been explored for their antimicrobial, anti-inflammatory, anti-oxidative, and anti-parasite properties (78–84) (Table 1). A good example is garlic extract, which is widely considered as one of the most effective antibiotic agents (86). In addition, Areca catechu is a rich source of compounds with anti- quorum sensing (QS) properties (87). Some studies also found that P. aeruginosa genes controlled by QS could be inhibited by the isothiocyanate iberin from horseradish and ajoene from garlic (88, 89). When they are combined with tobramycin, ajoene and horseradish juice extracts function as a synergistic antibacterial (90). Extracts of the genus Paeonia, one of the most important sources of drugs in Chinese traditional medicine, can inhibit C. albicans growth (91). Extracts from Fructus psoraleae, Folium eucalypti globuli and Achillea millefolium, anti-dermatophitic compounds, have been used to treat different ailments such as dermatomycosis in Chinese traditional medicines (92, 93).
Table 1
| Plant | Effect observed | References |
|---|---|---|
| Aged garlic extract, allicin | Improved growth performance, nutrient digestibility, intestinal microbial balance, immune response and meat quality in finishing pigs | (82) |
| Camellia sinensis | Improved gut health of post-weaning piglets and protection from E.coli challenge | (81) |
| Cinnamon essential oils, Cinnamaldehyde | Antimicrobial activity and improved immune response against e.g., Salmonella typhimurium in swine intestine | (83) |
| Carvacrol, cinnamaldehye, eugenol, etc. | Anti-inflammatory effects on porcine alveolar macrophages | (78) |
| Capsicum oleoresin, turmeric oleoresin, garlicon | Improved gut health and reduced frequency of diarrhea in weanling pigs | (79, 80) |
| Agrimonia procera | Growth performance, increased immune response and antioxidative effects in piglets | (84) |
| Chinese traditional herbal medicine (CTHM) | Beneficial effects on swine growth with improved final live weight, general digestibility and nitrogen retention | (85) |
Antibiotic alternatives: plant extracts.
Diarrhea is a common cause of intestinal diseases in children and animals including swine (94). Some studies have been conducted to find plant extracts for inhibiting the proliferation of E. coli. Khan et al. (95) found that pathogenic strains of E. coli are sensitive to the extracts of three plants (Acacia nilotica, Syzygium aromaticum and Cinnamum zeylanicum). Herb extracts from Pulsatilla chinensis, Sophora flavescens, Phellodendron amurense, Radix Astragali and Codonopsis pilosula (Franch) Nannf have been used to treat diarrhea of piglets in Chongqing, Southwest China (96). Because of the influence of harvesting method and other unknown factors (97), plant extracts have been limited by their variability (98). The current high cost also limits the wide use of herb extracts, but the further development of herb extracts may reduce the cost and expand their application in developing countries.
Xinjiang is one of the Chinese regions with high biodiversity. The flora include common bitter beans, Cynomorium, Ephedra, Ferula, liquorice, snow lotus, sea buckthorn, and others. Among these, bitter beans have antibacterial ingredients (99). Horse grass contains alkaloids that, when drunk, can inhibit the function of malignant tumors. Xinjiang Lithospermum and liquorice contain glycyrrhizinate, flavonoids and other medicinal ingredients. These plant ingredients have antibacterial effects on E. coli, paratyphoid Salmonella, Staphylococcus aureus, Bacillus subtilis and other common pathogens (100).
Future Perspective and Conclusions
Global organizations and developed countries have paid increasing attention to tackling the great risks of overuse and abuse of antibiotics and antibiotic resistance (101). For example, the World Health Assembly (WHA) commissioned the WHO to deliver a global action plan on antibiotic resistance in May 2014. The British government sponsored the £10 million Longitude Prize for the best solution for the resistance problem in June 2014. The President's Council of Advisors on Science and Technology in the USA released a report on antibiotic resistance in September 2014.
Slower than many European countries and the USA, China unveiled a national plan to tackle antibiotic resistance in August 2016 (102). The plan highlights the importance of reducing use of antibiotics in China's livestock husbandry. However, the implementation details of the plan are still unclear. Punishment for violations is still lacking. As for many action plans and laws in China, strict implementation is extremely important for reducing the use of antibiotics (103, 104). The plan also emphasizes the development of new antibiotics. As stated above, the high price of new antibiotics and alternatives limits their development (). In the action plan, the funding source for discovery of new antibiotics or alternatives, for example from government or industry, is still unclear. Antibiotics have been widely overused and abused in Chinese swine farms to prevent diseases. However, it is more important to improve the sanitation and hygiene conditions of swine farms. Rather than using antibiotics, some measures should be applied to improve the health and well-being of swine, in particular reducing animal overcrowding, and controlling facility temperature and ventilation. In addition to the swine farmers, joint efforts from government, academia and veterinary professionals are indispensable.
Antibiotic resistance has become a world-wide challenge and therefore international collaboration is increasingly crucial. International collaboration between the world's largest antibiotics consumers, China and Europe, is indispensable to tackle the AMR problem. The One Health approach is of importance to achieve a sustainable and effective management of AMR by joint efforts of the international community with involvement of all stakeholders.
Statements
Author contributions
JC and DL designed the review, contributed to writing and editing. HY, LP, XC, AvE, HS, and YW contributed to writing, while JC is responsible for submission.
Funding
This work is supported by Sinograin and Sinograin II projects with JC as the project manager.
Acknowledgments
This work was supported by the Sinograin project and a pilot project Biotransformation supported by NIBIO core funding. The authors thank Prof. Nicholas Clarke for linguistic correction.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
YangH. Livestock development in China: animal production, consumption and genetic resources. J Anim Breed Genet. (2013) 130:249–51. 10.1111/jbg.12045
2.
HeYYangXGXiaJZhaoLYYangYX. Consumption of meat and dairy products in China: a review. Proc Nutri Society. (2016) 75:385–91. 10.1017/S0029665116000641
3.
LiJ. (2017). Current status and prospects for in-feed antibiotics in the different stages of pork production- a review. Asian Austr J Animal Sci. 30:1667–73. 10.5713/ajas.17.0418t
4.
TangKLCaffreyNPNóbregaDBCorkSCRonksleyPEBarkemaHWet al. Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis. Lancet Planet Health. (2017) 1:316–27. 10.1016/S2542-5196(17)30141-9
5.
MenkemZENgangomBLTamunjohSSABoyomFF. Antibiotic residues in food animals: Public health concern. Acta Ecologica Sinica. (2018). 10.1016/j.chnacs.2018.10.004.
6.
BacanliMBaşaranN. Importance of antibiotic residues in animal food. Food Chem Toxicol. (2019) 125:462–6. 10.1016/j.fct.2019.01.033
7.
WHO. (2014). Antimicrobial Resistance: Global Report on Surveillance. Geneva.
8.
CameronAMcAllisterTA. Antimicrobial usage and resistance in beef produciton. J Animal Sci. 7:68. 10.1186/s40104-016-0127-3
9.
XiongWSunYXZengZ. Antimicrobial use and antimicrobial resistance in food animals. Env Sci Pollu Res. (2018) 25:18377–284. 10.1007/s11356-018-1852-2
10.
SarmahAKMeyerMTBoxallABA. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere. (2006) 65:725–59. 10.1016/j.chemosphere.2006.03.026
11.
MilanovDSLjubojevićDBCabarkapaISAleksićNŽ. Impact of antibiotics used as growth promoters on bacterial resistance. Food Feed Res. (2016) 43:83–92. 10.5937/FFR1602083M
12.
StokstadELRJukesTHPierceJPageACFranklinAL. The multiple nature of the animal protein factor. J Biol Chem. (1949) 180:647–54.
13.
CromwellGL. Why and how antibiotics are used in swine production. Anim Biotechnol. (2002) 13:7–27. 10.1081/ABIO-120005767
14.
ChengGYHaoHHXieSYWangXDaiMHHuangLLet al. Antibiotic alternatives: the substitution of antibiotics in animal husbandry?Front Microbiol. (2014) 5:00217. 10.3389/fmicb.2014.00217
15.
Van EppsABlaneyL. Antibiotic residues in animal waste: occurrence and degradation in conventional agricultural waste management practices. Curr Pollut Rep. (2016) 2:1–21. 10.1007/s40726-016-0037-1
16.
WangJHanJZ. Effects of heavy metals and antibiotics on soil and vegetables. J Ecol Rural Environ. (2008) 24:90–3. 10.3969/j.issn.1673-4831.2008.04.019
17.
ZhangHLuoYZhouQ. Research advancement of eco-toxicity of tetracycline antibiotics. J Agro-Environ Sci. (2008) 27:407–13. 10.3321/j.issn:1672-2043.2008.02.001
18.
ZhangHZhangMGuG. Residues of tetracyclines in livestock and poultry manures and agricultural soils from North Zhejiang Province. J Ecol Rural Environ. (2008) 24:69–73. 10.3969/j.issn.1673-4831.2008.03.014
19.
ZhangMWangLZhengS. Adsorption and transport characteristics of two exterior-source antibiotics in some agricultural soils. Acta Eco Sin. (2008) 28:761–6. 10.3321/j.issn:1000-0933.2008.02.038
20.
LiYMoCZhaoNTaiYBaoYWangJet al. Investigation of sulfonamides and tetracyclines antibiotics in soils from various vegetable fields. Environ Sci. (2009) 30:1762–6. 10.3321/j.issn:0250-3301.2009.06.035
21.
TaiYMoCLiYWuXZouXGaoPet al. Concentration and distribution of quinolone antibiotics in long-term manure-amended soils. China Environ Sci. (2010) 30:816–21.
22.
LiYWWuXLMoCHTaiYPHuangXPXiangL. Investigation of sulfonamide, tetracycline, and quinolone antibiotics in vegetable farmland soil in the Pearl River Delta area, southern China. J Agric Food Chem. (2011) 59:7268–76. 10.1021/jf1047578
23.
ZhangQQYingGGPanCGLiuYSZhaoJL. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ Sci Technol. (2015) 49:6772–82. 10.1021/acs.est.5b00729
24.
KrishnasamyVOtteJSilbergeldE. Antimicrobial use in Chinese swine and broiler poultry production. Antimicrob Resis Infect Control. (2015) 4:1–9. 10.1186/s13756-015-0050-y
25.
MellonMBenbrookCBenbrookK. Hogging It: Estimates of Antimicrobial Abuse in Livestock. (2001). Cambridge, MA: UCS Publications.
26.
JiXLLiuFShenQ. Quantitative detection of sulfonamides and tetracycline antibiotics and their resistance genes in farm wastewater. Chinese J Eco Environ Sci. (2011) 20:927–33. 10.3969/j.issn.1674-5906.2011.05.025
27.
XiaLZhaoHMikeremuSChengTGaoP. Survey on antibiotic resistance of E.coli isolated from different growth stage pigs in a pig farm of Xinjiang. Chinese J Animal Husb Vet Med. (2013) 40:216–9. 10.3969/j.issn.1671-7236.2013.03.049
28.
ChengJYuZMichelFCMorrisonM. Development and application of real-time pcr assays for quantification of erm genes conferring resistance to macrolides-lincosamides-streptogramin b in livestock manure and manure management systems. Environ Microbiol. (2007) 73:4407–16. 10.1128/AEM.02799-06
29.
ZhouTLiXWangXLuJ. Pollution analysis of antibiotic resistant genes of manas river basin, Xinjiang. J Shihezi University (Nat Sci Ed). (2014) 32:755–9. 10.3969/j.issn.1007-7383.2014.06.018
30.
WalshTRWuY. China bans colistin as a feed additive for animals. Lancet. (2016) 16:1102–3. 10.1016/S1473-3099(16)30329-2
31.
DuLFLiuWK. Occurrence, fate, and ecotoxicity of antibiotics in agro-ecosystems. A review Agron Sustain Dev. (2012) 32:309–27. 10.1007/s13593-011-0062-9
32.
MarshallBMLevySB. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. (2011) 24:718–33. 10.1128/CMR.00002-11
33.
MoleB. Farming up trouble. Nature. (2013) 499:398–400. 10.1038/499398a
34.
PrudenALarssonDGJAmézquitaACollignonPBrandtKKGrahamDWet al. Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect. (2013) 121:878–85. 10.1289/ehp.1206446
35.
SongWGuoM. Residual veterinary pharmaceuticals in animal manures and their environmental behaviors in soils. In: He, Z, Zhang, H, editors. Applied Manure and Nutrient Chemistry for Sustainable Agriculture and Environment, London: Springer. p. 23–52. (2014).
36.
BerendonkTUManaiaCMMerlinCFatta-KassinosDCytrynEWalshFet al. Tackling antibiotic resistance: the environmental framework. Nat Rev Microbiol. (2015) 13:310–7. 10.1038/nrmicro3439
37.
LandersTFCohenBWittumTELarsonEL. A Review of antibiotic use in food animals: perspective, policy, and potential. Public Health Rep. (2012) 127:4–22. 10.1177/003335491212700103
38.
ZhangRFEgglestonKRotimiVZeckhauserRJ. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health. (2006) 2:1–14. 10.1186/1744-8603-2-6
39.
HvistendahlM. Public health China takes aim at rampant antibiotic resistance. Science. (2012) 336:795. 10.1126/science.336.6083.795
40.
LarsonC. Pharmaceuticals China's lakes of pig manure spawn antibiotic resistance. Science. (2015) 347:704. 10.1126/science.347.6223.704
41.
HuYChengH. Health risk from veterinary antimicrobial use in China's food animal production and its reduction. Environ Pollut. (2016) 219:993–7. 10.1016/j.envpol.2016.04.099
42.
HansenLHJohannesenEBurmølleMSørensenAHSørensenSJ. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother. (2004) 48:3332–7. 10.1128/AAC.48.9.3332-3337.2004
43.
LiJZhangHNingJSajidAChengGYuanZet al. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. (2019) 8:44. 10.1186/s13756-019-0489-3
44.
WangJZhiCPChenXJGuoZWLiuWLLuoJHuangXYet al. Characterization of oqxAB in Escherichia coliIsolates from animals, retail meat, and human patients in guangzhou, China. Front Microbiol. (2017) 8:1982. 10.3389/fmicb.2017.01982
45.
ZhaoJJChenZLChenSDengYTLiuYHTianWet al. Prevalence and Dissemination of oqxAB in Escherichia coli Isolates from Animals, Farmworkers, and the Environment. Antimicrobial Agents Chemother. (2010) 54:4219–24. 10.1128/AAC.00139-10
46.
HansenLHSørensenSJJørgensenHSJensenLB. The prevalence of the OqxAB amongst olaquindox-resistant multidrug efflux pump Escherichia coli in pigs. Microbial Drug Resist Mech Epidemiol Dis. (2005) 11:378–82. 10.1089/mdr.2005.11.378
47.
BinKim HWangMHParkCHKimECJacobyGAHooperDC. oqxAB encoding a multidrug efflux pump in human clinical isolates of enterobacteriaceae. Antimicrob Agents Chemother. (2009) 53:3582–4. 10.1128/AAC.01574-08
48.
ZhangXYDingLJFanMZ. Resistance patterns and detection of aac(3)-IV gene in apramycin-resistant Escherichia coli isolated from farm animals and farm workers in northeastern China. Res Vet Sci. (2009) 87:449–54. 10.1016/j.rvsc.2009.05.006
49.
HoPLWongRCLoSWChowKHWongSSQueTL. Genetic identity of aminoglycoside-resistance genes in Escherichia coli isolates from human and animal sources. J Med Microbiol. (2010) 59:702–7. 10.1099/jmm.0.015032-0
50.
WebbHEGranierSAMaraultMMillemannYden BakkerHCNightingaleKKet al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. (2016) 16:144–5. 10.1016/S1473-3099(15)00538-1
51.
LiuYYWangYWalshTRYiLXZhangRSpencerJet al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. (2016) 16:161–8. 10.1016/S1473-3099(15)00424-7
52.
XiaLNZhaoHQSuYGuoQYChenTTGaoP. Resistance survey of Escherichia coli isolates to antibiotics from a hoggery in Xinjiang. Xinjiang Agricult Sci. (2012) 49:2299–303. 10.6048/j.issn.1001-4330.2012.12.024
53.
CastanonJ. History of the use of antibiotic as growth promoters in European poultry feeds. Poultry Sci. (2007) 86:2466–71. 10.3382/ps.2007-00249
54.
LaxminarayanR. Antibiotic effectiveness: Balancing conservation against innovation. Science. (2014) 345:1299–301. 10.1126/science.1254163
55.
LomovskayaOBostianKA. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem Pharmacol. (2006) 71:910–8. 10.1016/j.bcp.2005.12.008
56.
BowserTEBartlettVJGrierMCVermaAKWarcholTLevySBet al. Novel anti-infection agents: Small-molecule inhibitors of bacterial transcription factors. Bioorg Med Chem Lett. (2007) 17:5652–5. 10.1016/j.bmcl.2007.07.072
57.
JeonBZhangQJ. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter. J Antimicrob Chemother. (2009) 63:946–8. 10.1093/jac/dkp067
58.
PiddockLJVGarveyMIRahmanMMGibbonsS. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J Antimicrob Chemother. (2010) 65:1215–23. 10.1093/jac/dkq079
59.
PiddockLJV. The crisis of no new antibiotics-what is the way forward?Lancet Infect Dis. (2012) 12:249–53. 10.1016/S1473-3099(11)70316-4
60.
BarczakAKHungDT. Productive steps toward an antimicrobial targeting virulence. Curr Opin Microbiol. (2009) 12:490–6. 10.1016/j.mib.2009.06.012
61.
BaronC. Antivirulence drugs to target bacterial secretion systems. Curr Opin Microbiol. (2010) 13:100–5. 10.1016/j.mib.2009.12.003
62.
WilliamsP. Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiology. (2007) 153:3923–38. 10.1099/mic.0.2007/012856-0
63.
ChenGZSwemLRSwemDLStauffDLO'LoughlinCTJeffreyPDet al. A strategy for antagonizing quorum sensing. Mol Cell. (2011) 42:199–209. 10.1016/j.molcel.2011.04.003
64.
Garrity-RyanLKKimOKBalada-LlasatJMBartlettVJVermaAKFisherMLet al. Small molecule inhibitors of lcrf, a yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect Immun. (2010) 78:4683–90. 10.1128/IAI.01305-09
65.
LingLLSchneiderTPeoplesAJSpoeringALEngelsIConlonBPet al. A new antibiotic kills pathogens without detectable resistance. Nature. (2015) 517:455–9. 10.1038/nature14098
66.
BlaskovichMATZueggJElliottAGCooperMA. Helping chemists discover new antibiotics. Acs Infect Dis. (2015) 1:285–7. 10.1021/acsinfecdis.5b00044
67.
SmithPAKoehlerMFTGirgisHSYanDChenYChenYet al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature. (2018) 561:189–94. 10.1038/s41586-018-0483-6
68.
SealBSLillehojHSDonovanDMGayCG. Alternatives to antibiotics: a symposium on the challenges and solutions for animal production. Animal Health Res Rev. (2013) 14:78–87. 10.1017/S1466252313000030
69.
JoergerRD. Alternatives to antibiotics: Bacteriocins, antimicrobial peptides and bacteriophages. Poultry Sci. (2003) 82:640–7. 10.1093/ps/82.4.640
70.
LiuGMWeiYWangZSWuDZhouAGLiuGL. Effects of herbal extract supplementation on growth performance and insulin-like growth factor (IGF)-I system in finishing pigs. J Animal Feed Sci. (2008) 17:538–47. 10.22358/jafs/66681/2008
71.
ParisienAAllainBZhangJMandevilleRLanC. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Microbiol. (2008) 104:1–13. 10.1111/j.1365-2672.2007.03498.x
72.
SangYBlechaF. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Animal Health Res Rev. (2008) 9:227–35. 10.1017/S1466252308001497
73.
BaltzerSABrownMH. Antimicrobial peptides-promising alternatives to conventional antibiotics. J Mol Microbiol Biotechnol. (2011) 20:228–35. 10.1159/000331009
74.
SavoiaD. Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol. (2012) 7:979–90. 10.2217/fmb.12.68
75.
StantonTB. A call for antibiotic alternatives research. Trends Microbiol. (2013) 21:111–3. 10.1016/j.tim.2012.11.002
76.
OwensB. 2015 Nobel Prize goes to antiparasitic drug discoverers. Lancet. (2015) 386:1433. 10.1016/S0140-6736(15)00455-9
77.
TuYY. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. (2011) 17:1217–20. 10.1038/nm.2471
78.
LiuYSongMCheTMBravoDPettigrewJE. Anti-inflammatory effects of several plant extracts on porcine alveolar macrophages in vitro. J Anim Sci. (2012) 90:2774–83. 10.2527/jas.2011-4304
79.
LiuYCheTMSongMLeeJJAlmeidaJABravoDet al. Dietary plant extracts improve immune responses and growth efficiency of pigs experimentally infected with porcine reproductive and respiratory syndrome virus. J Anim Sci. (2013) 91:5668–79. 10.2527/jas.2013-6495
80.
LiuYSongMCheTMAlmeidaJALeeJJBravoDet al. Dietary plant extracts alleviate diarrhea and alter immune responses of weaned pigs experimentally infected with a pathogenic Escherichia coli. J Anim Sci. (2014) 91:5294–306. 10.2527/jas.2012-6194
81.
BontempoVJiangXRCheliFVersoLLMantovaniGVitariFet al. Administration of a novel plant extract product via drinking water to post-weaning piglets: effects on performance and gut health. Animal. (2014) 8:721–30. 10.1017/S175173111400041X
82.
LanRXParkJWLeeDWKimIH. Effects of astragalus membranaceus, codonopsis pilosula and allicin mixture on growth performance, nutrient digestibility, faecal microbial shedding, immune response and meat quality in finishing pigs. J. Animal Physi Animal Nutr. (2017) 101:1122–9. 10.1111/jpn.12625
83.
FriedmanM. Chemistry, antimicrobial mechanisms, and antibiotic activities of cinnamaldehyde against pathogenic bacteria in animal feeds and human foods. J. Agric. Food Chem. (2017) 65:10406–23. 10.1021/acs.jafc.7b04344
84.
GräberTKlugeHGranicaSHornGKalbitzJBrandschCet al. Agrimonia procera exerts antimicrobial effects, modulates the expression of defensins and cytokines in colonocytes and increases the immune response in lipopolysaccharide-challenged piglets. BMC Vet Res. (2018) 14:346. 10.1186/s12917-018-1680-0
85.
DuZRisuNGentuGCaiY. Growth performance, apparent digestibility, and N balance in Mongolian lambs and hoggs fed diets supplemented with a Chinese traditional herbal medicine complex. Anim Sci J. (2018) 89:1451–8. 10.1111/asj.13081
86.
ArnaultIChristidesJMandonNHaffnerTKahaneRAugerJ. High-performance ion-pair chromatography method for simultaneous analysis of alliin, deoxyalliin, allicin and dipeptide precursors in garlic products using multiple mass spectrometry and UV detection. J Chromatogr. (2003) 991:69–75. 10.1016/S0021-9673(03)00214-0
87.
KohKHThamFY. Screening of traditional Chinese medicinal plants for quorum-sensing inhibitors activity. J Microbiol Immunol. (2011) 44:144–8. 10.1016/j.jmii.2009.10.001
88.
JakobsenTHBragasonSKPhippsRKChristensenLDvan GennipMAlhedeMet al. Food as a source for QS inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa. Appl Environ Microbiol. (2012) 78:2410–21. 10.1128/AEM.05992-11
89.
JakobsenTHvan >GennipMPhippsRKShanmughamMSChristensenLDAlhedeMet al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother. (2012) 56:2314–25. 10.1128/AAC.05919-11
90.
ChristensenLDvan GennipMJakobsenTHAlhedeMHougenHPHøibyNet al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J Antimicrob Chemother. (2012) 67:1198–206. 10.1093/jac/dks002
91.
PicernoPMencheriniTSansoneFDel GaudioPGranataIPortaAet al. Screening of a polar extract of Paeonia rockii: composition and antioxidant and antifungal activities. J Ethnopharmacol. (2011) 138:705–12. 10.1016/j.jep.2011.09.056
92.
LauKMFuLHChengLWongCWWongYLLauCPet al. Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassay-guided purification. Am J Chin Med. (2010) 38:1005–14. 10.1142/S0192415X10008421
93.
FalconieriDPirasAPorceddaSMarongiuBGonçalvesMJCAMRalCet al. Chemical composition and biological activity of the volatile extracts of Achillea millefolium. Nat Prod Commun. (2011) 6:1527–30. 10.1177/1934578X1100601030
94.
LaineTMLyytikäinenTYliahoMAnttilaM. Risk factors for post-weaning diarrhoea on piglet producing farms in Finland. Acta Vet Scand. (2008) 50:1–11. 10.1186/1751-0147-50-21
95.
KhanRIslamBAkramMShakilSAhmadAAAliSMet al. Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. (2009) 14:586–97. 10.3390/molecules14020586
96.
DongSCaiHLiuZZhangSChenCLiuGet al. Antidiarrheal effects and mechanisms of several Chinese medicinal herb extractions. J China Agric Univ. (2005) 10:60–4. 10.3736/jintegrmed2013019
97.
BorovanL. Plant alkaloids enhance performance of animals and improve the utilizability of amino acids. Krmivarstvi. (2004) 6:36–7.
98.
BombaAJonecováZKoščováJNemcováRGancarčíkováSMudronováDet al. The improvement of probiotics efficacy by synergistically acting components of natural origin: a review. Biologia. (2006) 61:729–34. 10.2478/s11756-006-0149-y
99.
LiHWangHSongJLiXXieC. Climatic features and geographical distribution of medicinal plants in Xinjiang. Arid land Geograp. (2015) 38:36–42.
100.
AynazarZGhopurMAbdukadirAAlimjanAGulziraZ. Isolation of endophytic bacteria from Algagi pseudalhagi Desv and analysis of active metabolites. J Northwest Botanical Sci. (2012) 32:1466–73. 10.3969/j.issn.1000-4025.2012.07.028
101.
NathanCCarsO. Antibiotic resistance - problems, progress, and prospects. N Engl J Med. (2014) 371:1761–3. 10.1056/NEJMp1408040
102.
NHFPC. (2016). China National Action Plan to Contain Antimicrobial Resistance (2016-2020). National Health and Family Planning Commission of the P. R. China.
103.
YangH. China must continue the momentum of green law. Nature. (2014) 509:535–535. 10.1038/509535a
104.
YangHHuangXThompsonJRFlowerRJ. Enforcement key to China's environment. Science. (2015) 347:834–5. 10.1126/science.347.6224.834-d
Summary
Keywords
antibiotics, antimicrobial resistance, bacteria, China, human and animal health, swine production
Citation
Yang H, Paruch L, Chen X, van Eerde A, Skomedal H, Wang Y, Liu D and Liu Clarke J (2019) Antibiotic Application and Resistance in Swine Production in China: Current Situation and Future Perspectives. Front. Vet. Sci. 6:136. doi: 10.3389/fvets.2019.00136
Received
14 December 2018
Accepted
10 April 2019
Published
17 May 2019
Volume
6 - 2019
Edited by
Rajesh Jha, University of Hawaii At Manoa, United States
Reviewed by
Xiao Xu, Wuhan Polytechnic University, China; Sungkwonk Park, Sejong University, South Korea
Updates
Copyright
© 2019 Yang, Paruch, Chen, van Eerde, Skomedal, Wang, Liu and Liu Clarke.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Di Liu liudi1963@163.comJihong Liu Clarke Jihong.liu-clarke@nibio.no
This article was submitted to Animal Nutrition and Metabolism, a section of the journal Frontiers in Veterinary Science
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.